Viewing Study NCT02440958


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-02-21 @ 10:11 PM
Study NCT ID: NCT02440958
Status: COMPLETED
Last Update Posted: 2019-02-18
First Post: 2015-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module